期刊
BLOOD
卷 114, 期 17, 页码 3625-3628出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-05-220285
关键词
-
类别
资金
- National Cancer Institute [R01 CA96569, R01 CA103978, CA138402]
- Leukemia & Lymphoma Society Translational Research
- Multiple Myeloma Research Foundation
- Commonwealth Foundation for Cancer Research
Multiple myeloma remains an incurable disease. One of the major problems is that myeloma cells develop drug resistance on interaction with bone marrow stromal cells. In this study, we examined the effects of macrophages (M phi s), a type of stromal cells, on myeloma cell survival and response to chemotherapy. We showed that M phi, in particular tumor-associated M phi, is a protector of myeloma cells. The protective effect was dependent on direct contact between M phi s and myeloma cells. M phi s protected both myeloma cell lines and primary myeloma cells from spontaneous and chemotherapy drug-induced apoptosis by attenuating the activation and cleavage of caspase-dependent apoptotic signaling. These findings are clinically relevant because we found that CD68(+) M phi s heavily infiltrate the bone marrow of patients with myeloma but not the bone marrow of control patients. Thus, our results indicate that M phi s may contribute to myeloma cell survival and resistance to chemotherapeutic treatment in vivo. (Blood. 2009;114:3625-3628)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据